U.S. Semiconductors Stock News

NYSE:PHR
NYSE:PHRHealthcare Services

Phreesia (PHR) Turns Q2 Profit, Testing Long‑Running Bearish Profitability Narrative

Phreesia (PHR) just posted its latest quarterly scorecard with Q2 2026 revenue of about $117 million and basic EPS of $0.01, setting a clearer snapshot of where the business stands on its path toward profitability. The company has seen revenue move from roughly $102 million in Q2 2025 to $117 million in Q2 2026, while quarterly EPS has shifted from a loss of about $0.31 to a modest profit, giving investors fresh data on how quickly margins might be stabilizing from here. See our full analysis...
NYSE:CRGY
NYSE:CRGYOil and Gas

Does Crescent Energy’s Recent Rebound Signal a Mispriced Opportunity in 2025?

If you are wondering whether Crescent Energy is a quietly mispriced energy play or a value trap in the making, you are not alone. This breakdown aims to cut through the noise. Despite trading around $9.76, the stock has climbed 0.6% over the last week and 8.9% over the past month, even though it is still down 34.4% year to date and 30.5% over the last year. Much of this recent bounce has come as investors rotate back into select energy names and reassess companies with scale, cash flow and...
NasdaqGS:HSII
NasdaqGS:HSIIProfessional Services

Heidrick & Struggles Valuation After 2025 Share Price Surge and Pending Cash Buyout Deal

If you are wondering whether Heidrick & Struggles International is still a smart buy after such a strong run, you are not alone. This is exactly what we are going to unpack here. The stock has climbed 33.9% year to date and is up 30.4% over the last year, while longer term holders have seen gains of 108.8% over 3 years and 122.8% over 5 years, all from a recent close of $59.01. Those gains have come as investors have warmed to the company’s positioning in higher value advisory and leadership...
NYSE:QXO
NYSE:QXOTrade Distributors

Three Stocks That May Be Priced Below Their Estimated Worth In December 2025

As the U.S. market navigates a complex landscape with the Dow Jones Industrial Average reaching new heights and tech-heavy indices like the Nasdaq and S&P 500 experiencing pullbacks, investors are closely watching for opportunities amid fluctuating interest rates and economic data. In this environment, identifying stocks that may be undervalued requires careful consideration of their intrinsic worth relative to current market conditions, offering potential value in a diverse portfolio.
NasdaqGS:TMCI
NasdaqGS:TMCIMedical Equipment

Talkspace Leads These 3 Promising Penny Stocks

The U.S. stock market has been experiencing mixed movements, with the Dow Jones Industrial Average recently setting a new all-time high while the Nasdaq and S&P 500 have pulled back due to concerns over tech stocks. Despite these fluctuations, certain investment opportunities continue to capture attention, particularly in areas that offer affordability and potential growth. Penny stocks, though an outdated term, still represent smaller or newer companies that can provide significant value...
NYSE:LOAR
NYSE:LOARAerospace & Defense

Loar’s Expanded Undrawn Credit Capacity Might Change The Case For Investing In Loar Holdings (LOAR)

On November 25, 2025, Loar Holdings Inc. amended its Credit Agreement, increasing its delayed draw term loan commitment by US$175.0 million to US$275.0 million and extending the availability period through September 30, 2026, leaving the full US$275.0 million still undrawn as of that date. This expanded and extended loan capacity, together with fresh analyst coverage positioning Loar as a high-quality aerospace aftermarket M&A compounder, enhances the company’s financial flexibility to...
NasdaqGS:BLLN
NasdaqGS:BLLNHealthcare

BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses

BillionToOne (BLLN) has just put another big quarter on the board, with Q3 2025 revenue at about $62.8 million and Basic EPS of roughly -$0.20, as investors gauge how fast the top line can outrun still negative earnings. The company has seen revenue move from roughly $34.5 million in early 2024 to about $41.7 million later that year and then to $62.8 million in 2025, while Basic EPS shifted from about -$0.76 to -$1.30 and then to -$0.20 over the same stretch, setting up a story where rapid...
NYSE:NGVT
NYSE:NGVTChemicals

Has Ingevity’s 48.8% Rally in 2025 Outpaced Its Fundamental Recovery?

Wondering if Ingevity at around $58.83 is still a smart buy or if the easy money has already been made? You are not alone; this stock has quietly been drawing fresh attention from value focused investors. After a tough few years, the share price has surged, up 12.6% over the last week, 18.8% over the past month, and 48.8% year to date, even though the 3 and 5 year returns are still down 15.5% and 19.7% respectively. Part of this turnaround story reflects shifting sentiment around specialty...
NYSE:TPR
NYSE:TPRLuxury

Is It Too Late to Consider Tapestry After Its 92% 1 Year Surge?

If you are wondering whether Tapestry is still a buy after its big run, you are not alone. This stock has become a litmus test for how investors value premium brands in a changing consumer landscape. The share price has been on a tear, up 5.2% over the last week, 11.0% over the last month, and 79.4% year to date, capping off a 92.0% 1-year gain and multi-year returns north of 200%. Much of that momentum has been tied to headlines around Tapestry's portfolio strategy and brand investments,...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Is Ouster’s 108% Surge in 2025 Supported by Its Cash Flow Outlook?

Wondering if Ouster's huge run means you are late to the party or staring at an overlooked opportunity? Let's break down what the market is really pricing in here. The stock is up 108.3% year to date and 181.4% over the last year, even after a recent 1.0% dip over 7 days and a modest 3.7% gain across 30 days. This hints that sentiment has shifted fast, and risk perceptions are clearly changing. Much of this excitement has been driven by Ouster's push to scale its lidar technology into...